[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Bacterial Vaginosis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

October 2019 | 50 pages | ID: B575554B5AC2EN
VPAResearch

US$ 1,699.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Bacterial Vaginosis Drug pipeline report- 2020 is an annual R&D review of Bacterial Vaginosis pipeline candidates. The report presents the current status of all major Bacterial Vaginosis therapeutic compounds. Detailed insights into Bacterial Vaginosis pipeline development, current status, companies, drug profiles and Bacterial Vaginosis preclinical and clinical trials are included.

2020 Bacterial Vaginosis Pipeline Market Insights
Bacterial Vaginosis disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Bacterial Vaginosis therapies, pipeline by phase and others are included.

Bacterial Vaginosis pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Bacterial Vaginosis Therapeutic Drug candidates
Both active and inactive Bacterial Vaginosis pipeline drug candidates are included in the report

Bacterial Vaginosis Clinical Trials and preclinical Studies
Bacterial Vaginosis In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Bacterial Vaginosis pipeline market developments
Bacterial Vaginosis Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Bacterial Vaginosis pipeline companies in active development
The report analyzes Bacterial Vaginosis pipeline of the below companies-

Dare Bioscience Inc, Evofem Biosciences Inc, Hammock Pharmaceuticals Inc, Hennepin Life Sciences LLC, LUCA Biologics, Melinta Therapeutics, Next Science Ltd, Osel Inc, Pharmiva AB, Starpharma Holdings Ltd, TenNor Therapeutics Ltd, Toltec Pharmaceuticals LLC

Report Coverage

What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

Companies
12 Companies investing in Bacterial Vaginosis pipeline from discovery stage to pre-registration phase are included

Drug profiles
Over 10 details of each Bacterial Vaginosis pipeline candidate are included

Company Profiles
Business overview and contact details of all companies operating in the industry are provided

Market Developments
News, Developments and other recent industry developments are included
1. BACTERIAL VAGINOSIS PIPELINE MARKET INSIGHTS, 2020

1.1 Bacterial Vaginosis Disease Overview
1.2 Bacterial Vaginosis Drug Pipeline Snapshot, 2020
  1.2.1 Bacterial Vaginosis Pipeline Drugs by Phase
  1.2.2 Bacterial Vaginosis Pipeline Drugs by Company
  1.2.3 Bacterial Vaginosis Pipeline Drugs by Mechanism of Action
  1.2.4 Bacterial Vaginosis Pipeline Drugs by Route of Administration

2. BACTERIAL VAGINOSIS COMPANY WISE PIPELINE DETAILS

Dare Bioscience Inc Bacterial Vaginosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Evofem Biosciences Inc Bacterial Vaginosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Hammock Pharmaceuticals Inc Bacterial Vaginosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Hennepin Life Sciences LLC Bacterial Vaginosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
LUCA Biologics Bacterial Vaginosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Melinta Therapeutics Bacterial Vaginosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Next Science Ltd Bacterial Vaginosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Osel Inc Bacterial Vaginosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Pharmiva AB Bacterial Vaginosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Starpharma Holdings Ltd Bacterial Vaginosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
TenNor Therapeutics Ltd Bacterial Vaginosis Pipeline Drugs
  Company Profile
  Drug Candidate Details
Toltec Pharmaceuticals LLC Bacterial Vaginosis Pipeline Drugs
  Company Profile
  Drug Candidate Details

3. BACTERIAL VAGINOSIS DRUG PIPELINE PROFILES

3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. BACTERIAL VAGINOSIS PIPELINE NEWS AND DEVELOPMENTS

5. APPENDIX

5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts


More Publications